CONMED’s fourth-quarter results were well received by the market, driven by standout performance in its orthopedics portfolio ...
If you are wondering whether CONMED's current share price reflects its underlying value, this article will walk through what the numbers are saying and how to interpret them. CONMED's share price last ...
Zacks Investment Research on MSN
CONMED stock up post Q4 earnings and revenue beat, gross margin up
CONMED Corporation CNMD delivered adjusted earnings per share (EPS) of $1.43 in the fourth quarter of 2025, up 6.7% year over ...
StockStory.org on MSN
CONMED (NYSE:CNMD) beats Q4 CY2025 sales expectations, stock soars
Medical tech company CONMED (NYSE:CNMD) reported Q4 CY2025 results , with sales up 7.9% year on year to $373.2 million. On ...
NEW YORK (Reuters) - Activist investor Voce Capital Management LLC is pushing ConMed Corp (NSQ:CNMD) to pursue a sale, saying it believes the surgical-device maker could attract buyout interest from ...
Q4 earnings and 2026 outlook reframe the CONMED (CNMD) story CONMED (CNMD) just reported Q4 2025 results that paired higher sales with weaker profitability, while also laying out 2026 revenue guidance ...
CONMED Corporation (NYSE:CNMD) posted better-than-expected earnings for its fourth quarter, but issued FY25 earnings and revenue guidance below estimates. Conmed reported quarterly earnings of $1.34 ...
We think that DENTSPLY stock (NASDAQ NDAQ: XRAY), a dental equipment company, is currently a better pick than ConMed (NASDAQ: CNMD), a medical devices company that specializes in products for ...
CONMED Corporation CNMD is well poised for growth in the coming quarters, courtesy of its broad product spectrum. The optimism, led by the solid recurring revenue base and potential in General Surgery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results